The APAC MedTech investment landscape has seen significant declines in venture financing (-22%) and M&A deals (-37%) since 2021, driven by global challenges like market volatility, rising interest rates, inflation, and supply chain disruptions. With APAC’s ecosystem rated only 2 out of 5 compared to the U.S.’s 5, there is a pressing need for collective action from public and private stakeholders to improve capital allocation and support innovation.
APACMed members are invited to the webinar, “Accelerating APAC MedTech Growth with An Investment-Driven Ecosystem”, featuring insights from industry leaders and a whitepaper by L.E.K. Consulting and APACMed. The session will explore strategies to strengthen the ecosystem and drive growth in the region.
Featured Speakers:
Joaquin Lasso, SVP & General Manager Sports Medicine International, Smith & Nephew
Alessandro Falcone, Head, JLABS Singapore, Johnson & Johnson
Sampson Lau, President, PrimaNova Labs
Stephen Sunderland, APAC Managing Partner, L.E.K. Consulting
Wonder Wang, Engagement Manager, L.E.K. Consulting
This session is based on the whitepaper “Fueling the APAC MedTech Innovation Engine: An Ecosystem Investment“, which outlines challenges and actionable strategies to foster growth and innovation in the APAC MedTech industry.
Exclusively for APACMed Members. For enquiries, please contact [email protected].